Eisai Drug One Of Four In Trial To Treat Advanced Lung Cancer
This article was originally published in PharmAsia News
Executive Summary
Eisai's Targretin (bexarotene) for treating skin problems related to lymphoma is one of four drugs being tested for improving survival of lung-cancer patients